The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Speiser, D. E.
Right arrow Articles by Ohashi, P. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Speiser, D. E.
Right arrow Articles by Ohashi, P. S.

The Journal of Immunology, Vol 158, Issue 11 5185-5190, Copyright © 1997 by American Association of Immunologists

ARTICLES

TNF receptor p55 controls early acute graft-versus-host disease

DE Speiser, MF Bachmann, TW Frick, K McKall-Faienza, E Griffiths, K Pfeffer, TW Mak and PS Ohashi
Ontario Cancer Institute, Department of Medical Biophysics, University of Toronto, Canada.

Allogeneic bone marrow transplantation is frequently associated with graft-vs-host disease (GVHD). To understand the effector mechanisms of GVHD, we investigated the role of the TNF receptor p55 (TNFRp55), which is known to be important in inflammation and cytotoxicity. After the transplantation of allogeneic bone marrow and spleen cells to lethally irradiated mice, all wild-type recipients developed early lethal GVHD within 1 wk, whereas TNFRp55-deficient recipients had much reduced GVHD and survived for at least 3 wk. No defect in alloantigen presentation was found, since T cell proliferation and cytotoxicity were similar to allogeneic wild-type and TNFRp55-deficient stimulator and target cells. Also, TNF alpha release did not differ significantly between the two types of recipients. Therefore, early acute GVHD in wild-type mice was primarily due to TNFRp55-mediated tissue damage. Interestingly, lethal GVHD was not entirely dependent upon the TNFRp55. In experimental conditions using sublethal irradiation and high donor spleen cell numbers, TNFRp55-deficient recipient mice developed lethal GVHD with similar kinetics and frequency as the control mice. These data suggest that the effector mechanisms leading to organ damage in murine acute GVHD can be dissected in a cytokine pathway through the TNFRp55, as demonstrated here, and in a cellular pathway through direct interaction of cytotoxic lymphocytes with target tissues involving perforin and Fas/Fas ligand, as reported previously.


This article has been cited by other articles:


Home page
 BloodHome page
K. Sun, M. Li, T. J. Sayers, L. A. Welniak, and W. J. Murphy
Differential effects of donor T-cell cytokines on outcome with continuous bortezomib administration after allogeneic bone marrow transplantation
Blood, August 15, 2008; 112(4): 1522 - 1529.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
C. Borsotti, A. R. K. Franklin, S. X. Lu, T. D. Kim, O. M. Smith, D. Suh, C. G. King, A. Chow, C. Liu, O. Alpdogan, et al.
Absence of donor T-cell-derived soluble TNF decreases graft-versus-host disease without impairing graft-versus-tumor activity
Blood, July 15, 2007; 110(2): 783 - 786.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
J. M. El-Hayek, T. E. Rogers, and G. R. Brown
The role of TNF in hepatic histopathological manifestations and hepatic CD8+ T cell alloresponses in murine MHC class I disparate GVHD
J. Leukoc. Biol., October 1, 2005; 78(4): 1001 - 1007.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. A. Wysocki, S. B. Burkett, A. Panoskaltsis-Mortari, S. L. Kirby, A. D. Luster, K. McKinnon, B. R. Blazar, and J. S. Serody
Differential Roles for CCR5 Expression on Donor T Cells during Graft-versus-Host Disease Based on Pretransplant Conditioning
J. Immunol., July 15, 2004; 173(2): 845 - 854.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
S. Yamamoto, T. Tsuji, J. Matsuzaki, Y. Zhange, K. Chamoto, A. Kosaka, Y. Togashi, K. Sekikawa, K.-i. Sawada, T. Takeshima, et al.
Unexpected role of TNF-{alpha} in graft versus host reaction (GVHR): donor-derived TNF-{alpha} suppresses GVHR via inhibition of IFN-{gamma}-dependent donor type-1 immunity
Int. Immunol., June 1, 2004; 16(6): 811 - 817.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
G. Socie, J.-Y. Mary, M. Lemann, M. Daneshpouy, P. Guardiola, V. Meignin, L. Ades, H. Esperou, P. Ribaud, A. Devergie, et al.
Prognostic value of apoptotic cells and infiltrating neutrophils in graft-versus-host disease of the gastrointestinal tract in humans: TNF and Fas expression
Blood, January 1, 2004; 103(1): 50 - 57.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
G. R. Brown, E. L. Lee, and D. L. Thiele
TNF Enhances CD4+ T Cell Alloproliferation, IFN-{gamma} Responses, and Intestinal Graft-Versus-Host Disease by IL-12-Independent Mechanisms
J. Immunol., May 15, 2003; 170(10): 5082 - 5088.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
C. Schmaltz, O. Alpdogan, S. J. Muriglan, B. J. Kappel, J. A. Rotolo, E. T. Ricchetti, A. S. Greenberg, L. M. Willis, G. F. Murphy, J. M. Crawford, et al.
Donor T cell-derived TNF is required for graft-versus-host disease and graft-versus-tumor activity after bone marrow transplantation
Blood, March 15, 2003; 101(6): 2440 - 2445.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
G. R. Brown, E. Lee, and D. L. Thiele
TNF-TNFR2 Interactions Are Critical for the Development of Intestinal Graft-Versus-Host Disease in MHC Class II-Disparate (C57BL/6J->C57BL/6J x bm12)F1 Mice
J. Immunol., March 15, 2002; 168(6): 3065 - 3071.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
C. Schmaltz, O. Alpdogan, K. J. Horndasch, S. J. Muriglan, B. J. Kappel, T. Teshima, J. L. M. Ferrara, S. J. Burakoff, and M. R. M. van den Brink
Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect
Blood, May 1, 2001; 97(9): 2886 - 2895.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
B. B Aggarwal
Tumour necrosis factors receptor associated signalling molecules and their role in activation of apoptosis, JNK and NF-kappa B
Ann Rheum Dis, November 1, 2000; 59(90001): i6 - 16.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
T. Miura, D. Mizuki, S. Sasaki, S. Hasegawa, H. Sashinami, and A. Nakane
Host Resistance to Listeria monocytogenes Infection Is Enhanced but Resistance to Staphylococcus aureus Infection Is Reduced in Acute Graft-versus-Host Disease in Mice
Infect. Immun., July 1, 2000; 68(7): 4340 - 4343.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
N. Tsukada, H. Akiba, T. Kobata, Y. Aizawa, H. Yagita, and K. Okumura
Blockade of CD134 (OX40)-CD134L interaction ameliorates lethal acute graft-versus-host disease in a murine model of allogeneic bone marrow transplantation
Blood, April 1, 2000; 95(7): 2434 - 2439.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
G. R. Hill, T. Teshima, V. I. Rebel, O. I. Krijanovski, K. R. Cooke, Y. S. Brinson, and J. L. M. Ferrara
The p55 TNF-{alpha} Receptor Plays a Critical Role in T Cell Alloreactivity
J. Immunol., January 15, 2000; 164(2): 656 - 663.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. R. M. van den Brink, E. Moore, K. J. Horndasch, J. M. Crawford, J. Hoffman, G. F. Murphy, and S. J. Burakoff
Fas-Deficient lpr Mice Are More Susceptible to Graft-Versus-Host Disease
J. Immunol., January 1, 2000; 164(1): 469 - 480.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
D. Artis, N. E. Humphreys, A. J. Bancroft, N. J. Rothwell, C. S. Potten, and R. K. Grencis
Tumor Necrosis Factor {alpha} Is a Critical Component of Interleukin 13–mediated Protective T Helper Cell Type 2 Responses during Helminth Infection
J. Exp. Med., October 4, 1999; 190(7): 953 - 962.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
G. Dulude, D.-C. Roy, and C. Perreault
The Effect of Graft-versus-Host Disease on T Cell Production and Homeostasis
J. Exp. Med., April 19, 1999; 189(8): 1329 - 1342.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
N. Tsukada, T. Kobata, Y. Aizawa, H. Yagita, and K. Okumura
Graft-Versus-Leukemia Effect and Graft-Versus-Host Disease Can Be Differentiated by Cytotoxic Mechanisms in a Murine Model of Allogeneic Bone Marrow Transplantation
Blood, April 15, 1999; 93(8): 2738 - 2747.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
D. P. O'Brien, D. E. Briles, A. J. Szalai, A.-H. Tu, I. Sanz, and M. H. Nahm
Tumor Necrosis Factor Alpha Receptor I Is Important for Survival from Streptococcus pneumoniae Infections
Infect. Immun., February 1, 1999; 67(2): 595 - 601.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
P. J. Martin, Y. Akatsuka, M. Hahne, and G. Sale
Involvement of Donor T-Cell Cytotoxic Effector Mechanisms in Preventing Allogeneic Marrow Graft Rejection
Blood, September 15, 1998; 92(6): 2177 - 2181.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
K. Hattori, T. Hirano, H. Miyajima, N. Yamakawa, M. Tateno, K. Oshimi, N. Kayagaki, H. Yagita, and K. Okumura
Differential Effects of Anti-Fas Ligand and Anti-Tumor Necrosis Factor alpha  Antibodies on Acute Graft-Versus-Host Disease Pathologies
Blood, June 1, 1998; 91(11): 4051 - 4055.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
S. Ehl, J. Hombach, P. Aichele, T. Rulicke, B. Odermatt, H. Hengartner, R. Zinkernagel, and H. Pircher
Viral and Bacterial Infections Interfere with Peripheral Tolerance Induction and Activate CD8+ T Cells to Cause Immunopathology
J. Exp. Med., March 2, 1998; 187(5): 763 - 774.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1997 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1997 by The American Association of Immunologists, Inc. All rights reserved.